Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nancy Tray"'
Autor:
Elad Sharon, Jessica Taff, Jeffrey S. Ross, James Suh, Maryann Kwa, Razelle Kurzrock, Nhu Ngo, Sylvia Adams, Andrea B. Troxel, Young Kwang Chae, Carsten Denkert, Sandip Pravin Patel, Nancy Tray, Baljit Singh
Publikováno v:
The Breast. 44:29-32
Metaplastic breast cancer (MPBC) is a rare subtype that accounts for
Publikováno v:
Future Oncology. 14:2651-2661
Triple negative breast cancer (TNBC) is a heterogeneous disease that comprises 15–20% of all breast cancers and is more frequently seen in younger women, African–Americans, and BRCA1 expression. Advanced TNBC carries aggressive features and is as
Publikováno v:
Cancer treatment reviews. 79
Metaplastic breast carcinomas (MPBC) are rare, aggressive and relatively chemorefractory tumors with a high unmet need. While most are "triple negative" and lack expression of estrogen, progesterone and HER2 receptors, MPBC are associated with worse
Autor:
Virginia M. Klimek, Nancy Tray
Publikováno v:
Current Opinion in Hematology. 23:161-166
Purpose of review Therapy-related myeloid neoplasms (tMN) are increasingly recognized and studied diseases which have traditionally been defined clinically. With advances in methods used to study the genetics of aging and myeloid disease biology, nov
Autor:
Nancy Tray, Karen Hiotis, Deborah Axelrod, Victor Ty, Judith D. Goldberg, Farbod Darvishian, Maryann Kwa, Yelena Novik, Sylvia Adams, Amber A. Guth, James L. Speyer, Adriana Heguy, Douglas K. Marks
Publikováno v:
Cancer Research. 80:OT1-01
BACKGROUND: Receptor activator of NF-kB (RANK) and its ligand (RANKL) have a well-established role in osteoclast-driven bone remodeling, however RANK/RANKL expression can also be seen on mammary epithelial cells and immune cells (IC). In breast cance
Publikováno v:
Cancer immunology research. 6(10)
Immune-checkpoint blockade (ICB), in particular PD-1 inhibition, has rapidly changed the treatment landscape and altered therapeutic paradigms across many tumor types, with unprecedented rates of durable clinical responses in a number of cancers. Des
Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer
Autor:
Victor Ty, Francisco J. Esteva, Franco M. Muggia, Maryann J. Kwa, James L. Speyer, Sylvia Adams, Ruth Oratz, M Meyers, Andrea B. Troxel, Robert J. Schneider, Yelena Novik, Nancy Tray
Publikováno v:
Journal of Clinical Oncology. 37:TPS604-TPS604
TPS604 Background: Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer with poor prognosis and is often resistant to neoadjuvant chemotherapy with risk of early recurrence and systemic spread of disease. PD-L1 expression in
Publikováno v:
Stem Cells and Development. 19:1109-1120
Despite advances in clinical management, cardiovascular disease remains the leading cause of death in America. While cardiomyocytes retain limited plasticity following maturation, the heart is grossly unable to recover from structural damage. Mesench
Autor:
Karen A. Scott, Liang Yang, Kellie L.K. Tamashiro, Timothy H. Moran, Nancy Tray, Jayson Hyun, Sheng Bi
Publikováno v:
The Journal of Neuroscience. 29:179-190
Previous studies have suggested that neuropeptide Y (NPY) in the dorsomedial hypothalamus (DMH) serves as an important signaling peptide in the regulation of energy balance. To elucidate such actions, we used the adenoassociated virus (AAV) system to